New data suggests clinicians may be slower to recognize sepsis in people with pulmonary arterial hypertension.

Columnist Anna Jeter was recently reminded that she's still absorbing lessons from her chronic illness after 25 years of ...

Patients continued taking their medications for pulmonary arterial hypertension (PAH) when symptoms appeared to improve, ...

Significantly higher levels of the miRNA molecule miR-3591-5p were seen in those with CHD and moderate to severe PAH than ...

Positive study results for Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming patent ...

Winrevair was approved to treat pulmonary arterial hypertension (PAH), a progressive disorder caused by a constriction of ...

Merck announces pivotal phase 3 ZENITH trial evaluating Winrevair meets primary endpoint at interim analysis: Rahway, New Jersey Tuesday, November 26, 2024, 15:00 Hrs [IST] Merck, ...

The American Heart Association said that hunters should be advised that physical exertion, colder temperatures, and the ...

Eight months after snaring an inaugural FDA green light, Merck & Co. is bolstering the case for the chief asset in its $11.5 ...

Positive top-line results from the Phase III ZENITH study evaluating Winrevair (sotatercept-csrk) in adults with pulmonary ...

Augusta University is receiving millions of dollars aimed at helping scientists at the Medical College of Georgia understand ...